Free database of papers and journals






Results 1 to 20 of 1,136 articles found
2020

Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019

Cardiology in Review (2.3 57), 28, 266-271.
2020

Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?

2020

Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation

JAMA Cardiology (5.7 87), 5, 986.
2020

Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications

2016

Serpentine supravenous hyperpigmentation due to hydroxychloroquine

Vascular Medicine (2.1 75), 21, 558-559.
1963

Clinical Evaluation of Hydroxychloroquine, a Desludging Agent, in Angina Pectoris

Angiology (2.1 79), 14, 319-324.
2020

Effects of hydroxychloroquine treatment on QT interval

Heart Rhythm (3.6 144), 17, 1930-1935.
2020

Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research

International Journal of Cardiology (2.2 132), 316, 285-286.
2020

Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia

2007

Hydroxychloroquine-induced restrictive cardiomyopathy: Correlation between clinical, Echocardiographic and pathologic findings

2016

Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients

2020

Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection

2011

Hydroxychloroquine-Induced Cardiomyopathy

Circulation Heart Failure (4.7 118), 4, .
2021

Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19

Journal of Electrocardiology (0.8 74), 64, 30-35.
2021

Hydroxychloroquine/chloroquine and azithromycin in COVID-19 patients: prospective study of electrical parameters

REC, Cardioclinics (0.1 4), 56, 66-68.
2020

Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin

HeartRhythm Case Reports (0.7 13), 6, 241-243.
2020

[Communication] Incidence and determinants of QT interval prolongation in COVID-19 patients treated with hydroxychloroquine and azithromycin

2005

Hydroxychloroquine-induced Cardiotoxicity in a 39-year-old Woman with Systemic Lupus Erythematosus and Systolic Dysfunction

2020

QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin

2012

Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy

International Journal of Cardiology (2.2 132), 157, 117-119.
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor
EXALY
Authors
Journals
Institutions